USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	067572/0001			Pages:	9
		Recorded:	05/30/2024
Attorney Dkt #:	2383757KSPT
Conveyance:	AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT

Total properties: 13

Patent #:	NONE	Issue Dt:		Application #:	13494618	Filing Dt:	06/12/2012
Publication #:	US20130330761	Pub Dt:	12/12/2013
Title:	WHOLE CELL ASSAYS AND METHODS

Patent #:	9404915	Issue Dt:	08/02/2016	Application #:	14590731	Filing Dt:	01/06/2015
Publication #:	US20150125894	Pub Dt:	05/07/2015
Title:	WHOLE CELL ASSAYS AND METHODS

Patent #:	11073509	Issue Dt:	07/27/2021	Application #:	15179119	Filing Dt:	06/10/2016
Publication #:	US20170067875	Pub Dt:	03/09/2017
Title:	ASSAYS AND METHODS FOR DETERMINING THE RESPONSIVENESS OF AN INDIVIDUAL SUBJECT TO A THERAPEUTIC AGENT

Patent #:	10041934	Issue Dt:	08/07/2018	Application #:	15192280	Filing Dt:	06/24/2016
Publication #:	US20160305932	Pub Dt:	10/20/2016
Title:	WHOLE CELL ASSAYS AND METHODS

Patent #:	NONE	Issue Dt:		Application #:	15533897	Filing Dt:	06/07/2017
Publication #:	US20170343554	Pub Dt:	11/30/2017
Title:	METHODS OF MEASURING ERBB SIGNALING PATHWAY ACTIVITY TO DIAGNOSE AND TREAT CANCER PATIENTS

Patent #:	11591573	Issue Dt:	02/28/2023	Application #:	15950739	Filing Dt:	04/11/2018
Publication #:	US20180230434	Pub Dt:	08/16/2018
Title:	METHODS OF PREPARING A PRIMARY CELL SAMPLE

Patent #:	10976307	Issue Dt:	04/13/2021	Application #:	16027073	Filing Dt:	07/03/2018
Publication #:	US20180321222	Pub Dt:	11/08/2018
Title:	WHOLE CELL ASSAYS AND METHODS

Patent #:	11333659	Issue Dt:	05/17/2022	Application #:	16116392	Filing Dt:	08/29/2018
Publication #:	US20190025287	Pub Dt:	01/24/2019
Title:	METHODS OF MEASURING SIGNALING PATHWAY ACTIVITY FOR SELECTION OF THERAPEUTIC AGENTS

Patent #:	NONE	Issue Dt:		Application #:	17193891	Filing Dt:	03/05/2021
Publication #:	US20210215673	Pub Dt:	07/15/2021
Title:	WHOLE CELL ASSAYS AND METHODS

Patent #:	NONE	Issue Dt:		Application #:	17720067	Filing Dt:	04/13/2022
Publication #:	US20230125427	Pub Dt:	04/27/2023
Title:	METHODS OF MEASURING SIGNALING PATHWAY ACTIVITY FOR SELECTION OF THERAPEUTIC AGENTS

Patent #:	NONE	Issue Dt:		Application #:	17835208	Filing Dt:	06/08/2022
Publication #:	US20220412957	Pub Dt:	12/29/2022
Title:	METHODS OF TREATING CANCER PATIENTS WITH RAS NODE OR RTK TARGETED THERAPEUTIC AGENTS

Patent #:	NONE	Issue Dt:		Application #:	17872721	Filing Dt:	07/25/2022
Publication #:	US20230022525	Pub Dt:	01/26/2023
Title:	METHODS FOR THE TREATMENT OF CANCER USING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA

Patent #:	NONE	Issue Dt:		Application #:	18100437	Filing Dt:	01/23/2023
Publication #:	US20230235293	Pub Dt:	07/27/2023
Title:	METHODS OF PREPARING A PRIMARY CELL SAMPLE

Assignor

Exec Dt:

05/30/2024

Assignee

777 THIRD AVENUE, 25TH FLOOR

NEW YORK, NEW YORK 10017

Correspondence name and address
	KHADIJAH SAMPSON
	1025 CONNECTICUT AVE NW, SUITE 712
	COGENCY GLOBAL INC.
	WASHINGTON, DC 20036

Search Results as of: 06/27/2024 02:05 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6